MACE-5 (all-cause death, MI, stroke, heart failure event, coronary revascularisation) 44 events on retatrutide, 52 on placebo: In-study: HR 0.82 (95% CI 0.551.22) On-treatment: HR 0.73 (95% CI 0.471.12) MACE-3 (CV death, MI, stroke) 27 events on retatrutide, 23 on placebo: In-study: HR 1.12 (95% CI 0.641.96) On-treatment: HR 0.92 (95% CI 0.511.65) Lilly states plainly that MACE occurred less frequently than anticipated in both arms
Finally, the remaining papers studied patients with alcohol use disorder (2), anorexia nervosa (1), acquired hypothalamic damage (1), Prader-Willi syndrome (1), and major depressive disorder (1)
But for now, discount-loving Americans will have to bide their time.
As depicted in the figure below, these patients were directed to administer 5 units from a vial
T.BourcierT.et al (2014)
Pantoprazole is safe with antacids